1) pathogenic diabetic mouse model
病因性糖尿病模型
1.
Objective: To observe the effects of Saponin Extracted from Zea Mays L(ZMLS) on reducing blood sugar in pathogenic diabetic mouse models.
方法:采用静脉注射小剂量的四氧嘧啶加灌服葡萄糖造小鼠病因性糖尿病模型,通过血糖、血清胰岛素、胰岛细胞病理改变观察小鼠玉米须总皂苷对其影响。
2) diabetic model
糖尿病模型
1.
OBJECTIVE To explore the effect of Saponin extracted from Zea Mays L(ZMLS) on the morphologies of kidney,abdominal salivary gland,thoracic gland tissue for diabetic model rat induced by streptozocin(STZ).
kg-1造成的糖尿病模型大鼠为研究对象,将模型大鼠分为5组,分别灌服大、中、小剂量的玉米须总皂苷溶液、二甲双胍溶液和同体积生理盐水,另设一组空白对照组,给予同体积生理盐水。
2.
METHODS: Some animal models in this study included the glucose induced hyperglycemic model in mice, the alloxan induced diabetic model in mice and rats, and the HCSS induced insulin resistance model in mice.
方法 :用小鼠和大鼠建立葡萄糖性高血糖及四氧嘧啶性糖尿病模型 ,氢化可的松琥珀酸纳 (HCSS)诱导胰岛素抵抗 ,观察丹皮多糖 2b对正常和高血糖模型动物的影响 ,并测定糖尿病动物SOD、Insulin、GHb、ApoA1等水平。
3.
Objective To investigate the best experimental conditions of diabetic model induced by alloxan in Wistar rats.
结论 用四氧嘧啶制备糖尿病模型是一种经济可靠的实验方法。
4) mice
糖尿病模型
1.
Objective: To optimize the experimental conditions for establishing a diabetes mice model with alloxan.
目的:优化四氧嘧啶致小鼠糖尿病模型建立的实验条件;评价模型的稳定性。
2.
Objective:To optimize the experimental conditions for establishing a diabetes mice model with alloxan.
目的：优化四氧嘧啶致小鼠糖尿病模型建立的实验条件；评价模型的稳定性。
6) alloxan-induced diabetes mellitus
实验性糖尿病模型
补充资料：糖尿病非酮症性高渗性昏迷
糖尿病非酮症性高渗性昏迷
diabetic hyperosmolar nonketotic coma
糖尿病患者由于感染、尿毒症、电解质紊乱、甲亢、尿崩症等原因使血糖升高引起渗透性利尿，细胞内失水，特别是脑细胞可引起昏迷和死亡。特点起病慢，常被诱发本病的疾病或伴随症状所掩盖。早期呈原有糖尿病症状加重，嗜睡，逐渐进入昏迷状态。血糖＞28～54mmol/L，血钠＞145mmol/L，血浆渗透压＞310mmol/L，血、尿酮体无明显增高，无酸中毒。用等渗液或低于血浆渗透压40mmol/L的高渗液治疗，予以小剂量胰岛素，防止因血糖降低使血浆渗透压下降过快引起脑水肿。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条